- Home
- APLM vs BPT Comparison
APLM vs BPT Comparison
Compare APLM & BPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- BPT
- Stock Information
- Founded
- APLM 2016
- BPT 1989
- Country
- APLM United States
- BPT United States
- Employees
- APLM N/A
- BPT N/A
- Industry
- APLM Blank Checks
- BPT Integrated oil Companies
- Sector
- APLM Finance
- BPT Energy
- Exchange
- APLM Nasdaq
- BPT Nasdaq
- Market Cap
- APLM 12.3M
- BPT 13.0M
- IPO Year
- APLM N/A
- BPT N/A
- Fundamental
- Price
- APLM $7.02
- BPT $0.61
- Analyst Decision
- APLM Strong Buy
- BPT
- Analyst Count
- APLM 2
- BPT 0
- Target Price
- APLM $425.00
- BPT N/A
- AVG Volume (30 Days)
- APLM 7.4K
- BPT 206.7K
- Earning Date
- APLM 03-04-2025
- BPT 03-13-2025
- Dividend Yield
- APLM N/A
- BPT N/A
- EPS Growth
- APLM N/A
- BPT N/A
- EPS
- APLM N/A
- BPT N/A
- Revenue
- APLM $2,101,000.00
- BPT $257,000.00
- Revenue This Year
- APLM N/A
- BPT N/A
- Revenue Next Year
- APLM N/A
- BPT N/A
- P/E Ratio
- APLM N/A
- BPT N/A
- Revenue Growth
- APLM 70.54
- BPT N/A
- 52 Week Low
- APLM $6.38
- BPT $0.40
- 52 Week High
- APLM $80.50
- BPT $3.20
- Technical
- Relative Strength Index (RSI)
- APLM 37.88
- BPT 51.48
- Support Level
- APLM $6.70
- BPT $0.61
- Resistance Level
- APLM $7.60
- BPT $0.68
- Average True Range (ATR)
- APLM 0.70
- BPT 0.05
- MACD
- APLM -0.03
- BPT 0.01
- Stochastic Oscillator
- APLM 22.30
- BPT 52.29
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About BPT BP Prudhoe Bay Royalty Trust
BP Prudhoe Bay Royalty Trust is a grantor trust operating in the US. The property of the Trust consists of an overriding royalty interest. The Royalty Interest entitles the Trust to receive the royalty from the production of crude oil and condensate from the working interest of BP Exploration (Alaska) Inc. in the Prudhoe Bay oil field located on the North Slope of Alaska.